Pediatric tuberculosis (TB) often goes undiagnosed because of the lack of reliable diagnostic methods. With the aim of assessing biomarker(s) that can aid in the diagnosis of TB infection and disease, we investigated 746 Indian children with suspected TB. Whole-blood mRNA from 210 children was examined by dual-color Reverse-Transcriptase Multiple Ligation-dependent ProbeAmplification for the expression of 45 genes and a Bio-Plex assay for the expression of cytokines/chemokines in QuantiFERON supernatants. The study shows that transcription of SEC14L1, GUSB, BPI, CCR7 and TGFb-1 (all Pp0.05) was downregulated in TB disease compared with uninfected controls, while transcription of RAB33A was downregulated in TB disease compared with both latent TB (Po0.05) and controls (Po0.01). The transcription of CD4, TGFb-1 (Po0.01) and the expression of IL-2 (Po0.01) and IL-13 (Po0.05) was upregulated in latent TB compared with that in controls. Using the Least Absolute Shrinkage and Selection Operator (lasso) model, RAB33A alone discriminated between TB disease and latent TB (area under the curve (AUC) 77.5%), whereas a combination of RAB33A, CXCL10, SEC14L1, FOXP3 and TNFRSF1A was effective in discriminating between TB disease and controls (AUC 91.7%). A combination of 11 biomarkers predicted latent TB with moderate discriminatory power (AUC 72.2%). In conclusion, RAB33A is a potential biomarker for TB disease, whereas CD4, TGFb-1 and IL-2, IL-13 may identify latent TB in children.
INTRODUCTION
Tuberculosis (TB) constitutes a serious global health problem. In 2011, there were an estimated 8.7 million incident cases and 1.0 million deaths and India had the largest number (2.0-2.5 million) of incident cases reported globally. 1 The recent WHO global TB report estimated 0.5 million cases and 64 000 deaths among (HIVnegative) children o15 years, contributing to B6% of the disease burden globally (in 2011). 1 The immune system in infants is immature and gradually evolves throughout childhood, [2] [3] [4] affecting the ability to cope with infections. Thus, children aged o5 years have an increased risk of progression to TB disease following Mycobacterium tuberculosis infection and develop more severe disease. [5] [6] [7] The diagnosis of TB in children is traditionally based on chest radiography, tuberculin skin testing (TST) and mycobacterial staining/culture, even if these investigations may not always be positive in children with TB. 8 Commercially available interferongamma release assays (IGRAs) are being used in the diagnosis of M. tuberculosis infection in adults and children. The sensitivity of IGRAs and TST for TB disease is similar, and a reduced IGRA sensitivity has been found in high-burden compared with that in low-burden TB settings. 9 However, IGRAs have increased specificity compared with TST as they are not compromised by exposure to non-tuberculous mycobacteria (NTM) or Bacillus Calmette-Guerin (BCG) vaccination. However, WHO does not support the use of IGRAs in children because of the poor performance of the tests in low-and middle-income countries. 10 Moreover, the 2012 WHO global TB report states that neither TST nor IGRAs can discriminate between latent TB infection and TB disease.
1 Therefore, development of tests that accurately distinguish between M. tuberculosis infection and disease are essential. 11 One of the reasons for the intensive search for diagnostic and predictive biomarkers for TB is the lack of a gold standard for the diagnosis of M. tuberculosis infection and disease in children. 12 In attempts to discriminate between latent TB infection and TB disease, studies looking for potential biomarker(s) for TB in different populations, as well as studies looking at interactions between M. tuberculosis and its host, have been conducted. However, few studies have been conducted in young children. [13] [14] [15] The present study is nested within a prospective childhood cohort study, which was set up by the TB Trials Study Group in a typical rural population in Southern India. A childhood cohort study was designed to prepare a field site for future vaccine trials and establish the true incidence of TB disease among children followed up within 15 days of birth to 2 years of age. As part of the childhood cohort study, the present study was set up to look for potential biomarkers for M. tuberculosis infection and disease in young children referred from the cohort for a diagnostic work up for TB during the follow-up period. Accordingly, in appropriately selected samples from these children, we have assessed the transcriptional levels of a predefined panel of genes of interest using novel high-throughput technology (dual-color ReverseTranscriptase Multiple Ligation-dependent Probe-Amplification; dcRT-MLPA). 16 Furthermore, the expression of selected chemokines/cytokines, at the protein level, was assessed using a multiplex bead assay.
RESULTS
Nested case-control study group characteristics Baseline characteristics for the study groups are provided in Table 1 . Age (in months; P ¼ 0.011), proportion of children with failure to thrive Po0.001) and malnutrition (weight-for-height Zscore (WHZ); Po0.001 and weight-for-age Z-score (WAZ); P ¼ 0.017) were differently distributed between the clinical groups. The proportion of TB disease cases was found to be higher in the 0-12 (30.8%) and 13-24 (53.8%) months age categories (Table 1) . Children classified with TB disease and latent TB were more likely to have persistent cough and a history of TB contact compared with uninfected controls (both Po0.001). The proportion of NTMpositive cases was higher in the uninfected controls versus those with TB disease and the latent TB group (P ¼ 0.029). Unexpectedly, the majority of infants classified with TB disease did not have a positive TST or QuantiFERON-TB Gold In-tube (QFT-GIT; Cellestis Inc, Valencia, CA, USA) ( Table 1) .
Identification of gene signatures
We analyzed the dcRT-MLPA data using the global test for a pairwise comparison between TB disease versus latent TB, TB disease versus uninfected controls and latent TB versus uninfected controls. The binary outcome from the global test showed that none of the genes were associated with the three clinical groups (Supplementary Figure 1) . Differences in baseline characteristics were identified by the Pearson's w 2 test (with Yates continuity correction) or Fisher's exact test where appropriate, and used for adjusting the confounders. As cough, history of exposure to TB, failure to thrive, chest X-ray (CXR) changes, TST and QFT-GIT were used as selection criteria for referring children to the TB case verification ward (CVW)/classification to clinical groups, binary logistic regression analysis was performed with and without adjusting for age (months), nutritional status (WHZ and WAZ) and culture positivity for NTM. The unadjusted and adjusted results are shown in Table 2 .
The results from the adjusted analysis were plotted and shown in Figure 1 . The transcription of RAB33A was downregulated in children with TB disease compared with that in latent TB (P ¼ 0.015) and uninfected controls (P ¼ 0.002) (Figure 1a) . Conversely, transcription of TGF-b1 was upregulated in children with TB disease (P ¼ 0.015) and latent TB (P ¼ 0.003), compared with that in uninfected controls (Figure 1b) . Similarly, the transcription of CD4 (P ¼ 0.006) was upregulated in the latent TB group compared with that in uninfected controls (Figure 1c ). Children with TB disease had reduced transcription for CCR7 (P ¼ 0.038), BPI (P ¼ 0.046) SEC14L1 (P ¼ 0.05) and GUSB (P ¼ 0.05) compared with uninfected controls (Figures 1d-g ). In unadjusted analysis, the transcription of FOXP3 was downregulated in TB disease compared with latent TB (P ¼ 0.025), whereas the transcription of TNFRSF1A (P ¼ 0.047) was upregulated in the latent TB compared with uninfected controls (Table 1) ; however, these markers failed to reach statistical significance in adjusted analysis (Figures 1h and i, respectively) .
The least absolute shrinkage and selection operator (lasso) regression analysis was performed on dcRT-MLPA data with and without adjusting for age (months), nutritional status (WHZ and WAZ) and culture positivity for NTM. For TB disease versus latent TB group, RAB33A alone gave an area under the curve (AUC) of 85.0 and 77.5% for unadjusted and adjusted analysis (Figures 2a  and d, respectively) . For TB disease versus uninfected controls, the combination of SEC14L1 and RAB33A gave an AUC of 81.3% (unadjusted; Figure 2b ) and the combination of CXCL10, SEC14L1, FOXP3, RAB33A and TNFRSF1A presented an AUC of 91.7% (adjusted; Figure 2e ). The biomarkers proposed by both models were RAB33A and SEC14L1. Similarly, for the latent TB versus uninfected controls, the combination of CD4, SEC14L1, TGFb1 and TNFRSF1A provided an AUC of 60.1% (unadjusted; Figure 2c ) and a combination of 11 biomarkers: CXCL10, CD4, SEC14L1, IL4, RAB33A, TGFBR2, BCL2, TGFb1, TNFRSF1B, RAB13 and CD19 gave an AUC of 72.2% (adjusted; Figure 2f ). Again, the biomarkers proposed by both models were CD4, SEC14L1 and TGFb1 (Figure 2 ).
Identification of cytokine/chemokine profiles The assessment of the association of the selected cytokine/ chemokine biomarkers in the 10-plex assay, between the clinical categories (pair-wise comparison) was undertaken by the global test. Global test analysis showed that none of the selected cytokines/chemokines (from TB-specific antigen-stimulated tubes) could differentiate between the three clinical groups (Supplementary Figure 2) . The results from the binary logistic regression analyses (unadjusted and adjusted for age in months, WHZ, WAZ and culture positivity for NTM) are shown in Table 3 .
As shown in Figure 3 , compared with uninfected controls, the expression of IL-2 (P ¼ 0.009) and IL-13 (P ¼ 0.047) was higher in children with latent TB (Figures 3a and b) . The expression of MCP-1 and IP-10, although not approaching statistical significance (P ¼ 0.07), was somewhat higher in latent TB compared with that in uninfected controls (Figures 3c & d) .
The lasso regression models (unadjusted and adjusted for age in months, nutritional status (WHZ and WAZ) and culture positivity for NTM) proposed a combination of biomarker signatures for the three clinical groups (TB disease vs. uninfected controls; TB disease vs latent TB and latent TB vs uninfected controls), as shown in Supplementary Figure 3 . Lasso regression analysis identified a combination of IL-2 and IL-8 that could differentiate with moderate power (AUCB70.0%) between TB disease and latent TB, but was unable to identify a biomarker signature with sufficient discriminatory power for the other clinical categories (Supplementary Figure 3) .
DISCUSSION
TB in children is a devastating problem globally; young children are at increased risk of developing disseminated TB disease and death. 14, 17, 18 There is a need for potential TB biomarker(s) that can differentiate between subjects with TB disease and latent TB infection, indicate the reactivation risk for latent TB subjects, predict treatment success and provide immune correlates of protection against TB by new vaccines. 19 In the present study, conducted in a setting where TB is prevalent, we screened for biomarkers with the potential to discriminate between TB disease, latent TB infection and uninfected controls in children suspected of having TB. A predefined panel of 45 genes was assessed in unstimulated whole-blood samples from these children, using novel high-throughput technology (dcRT-MLPA), which is inexpensive and equally robust as qPCR. 16 Further, the concentration of cytokines/chemokines in the supernatants from TB-specific antigen-stimulated and unstimulated whole blood were analyzed using a Bio-plex assay.
The transcription of RAB33A was downregulated in children with TB disease compared with children with latent TB and uninfected controls in both unadjusted and adjusted analysis. The transcription of FOXP3 was downregulated in children with TB disease compared with latent TB in unadjusted analysis (Po0.05), although it failed to reach statistical significance in adjusted analysis (P ¼ 0.08). Unadjusted and adjusted (for age in months, nutritional status (WHZ and WAZ) and culture positivity for NTM) lasso regression models identified RAB33A that could differentiate between TB disease and latent TB with a good discriminatory power (AUC: 85.0%, 77.5%, respectively). RAB33A is a small guanosine triphosphatase (GTPase) suggested to be involved in vesicle transport and fusion. 20 Dysregulation of GTPases have been shown to have a role in blocking phagosome maturation, 21 which is a major survival strategy for M. tuberculosis. 22, 23 Earlier studies from Caucasian and South African adults have shown a downregulation of the expression of RAB33A, CD64 (Fcg receptor 1A) and LTF (lactoferrin) in unstimulated peripheral blood mononuclear cells (PBMCs) from patients with TB disease. [24] [25] [26] To our knowledge, this is the first study to identify RAB33A as a potential biomarker for TB disease in young Indian children.
FOXP3 is a crucial regulator of the development and function of regulatory T-cells. 27 Evidence suggests that FOXp3 þ regulatory T-cells can have both protective and detrimental roles in host defense against infection. 28 Previous studies have shown that the expression of FOXP3 is increased in adults with active TB. [29] [30] [31] Furthermore, Burl et al. 32 reported that during early TB infection, the expression of FOXP3 is reduced and subsequently increased during TB disease. In the present study, we found that in unadjusted binary logistic regression analysis, the expression of FOXP3 was significantly downregulated in the TB disease group, as compared with the latent TB group (P ¼ 0.025), whereas in adjusted analysis it did not maintain statistical significance (P ¼ 0.08).
Compared with that in uninfected controls, the transcription of TGFb1 was upregulated in children with TB infection (Po0.01) and TB disease (Po0.05). Similarly, CD4 was also upregulated in latent TB infection (Po0.01), but not in TB disease. Reports have shown that the expression of TGF-b is increased in adult with TB disease. 29, 33, 34 TGF-b1 performs many cellular functions including control of cell growth, proliferation and differentiation. Furthermore, it is an anti-inflammatory marker, and involved in Biomarkers for TB infection and disease S Dhanasekaran et al the wound-healing process of granulomatous lesions in patient with TB disease. 34 CD4 has a major role in adaptive immunity to TB. 16 Thus, the differential expression in young children of TGFb1 and CD4, both previously shown to have a role in the host responses to TB, is not unexpected. The combination of 11 biomarkers (CXCL10, CD4, SEC14L1, IL4, RAB33A, TGFBR2, BCL2, TGFb1, TNFRSF1B, RAB13 and CD19) identified by the lasso regression model gave only moderate discriminatory power (AUC 72.2%) to differentiate between latent TB and uninfected controls (Figure 2f) .
The transcription of SEC14L1, RAB33A, GUSB, CCR7, BPI, and TGFb1 was differentially expressed between children with TB disease and uninfected controls. For TB disease, RAB33A, SEC14L1, TGFb1 and for latent TB, CD4 and TGFb1 were identified as potential biomarkers in both unadjusted and adjusted binary logistic regression analysis, whereas CCR7, BPI and GUSB were only identified in the TB disease group by adjusted regression analysis. CCR7 is a chemokine receptor that controls the migration of antigen-presenting cells to the lymph node (ligands CCL19, CCL21) where the adaptive immune response is initiated. CCR7 has specifically been shown to mediate trafficking of dendritic cells from the lungs to the mediastinal lymph node during TB disease.
35 SEC14-like protein 1 belongs to the SEC14 cytosolic factor family, which has a role in the intracellular transport system, 36 whereas BPI encodes a lipopolysaccharide-binding protein associated with human neutrophil granules. Earlier findings have shown that the serum BPI concentration is elevated in TB disease. 37 In the mouse model, Vishwanath et al. 38 have shown an increased b-glucuronidase (GUSB) activity during phagocytosis of M. tuberculosis by peritoneal macrophages. In contrast, the findings from the current study in young children suggest that the expression of BPI and GUSB is reduced in TB disease, perhaps due to the pathogen interference with intracellular trafficking of phagocytes. Adjusted lasso regression analysis identified a combination of CXCL10, SEC14L1, FOXP3, RAB33A and TNFRSF1A that could differentiate with excellent discriminatory power (AUC 91.7%) between TB disease and uninfected controls.
Young children recruited in the childhood cohort study study conducted in Palamaner taluk, Southern India, were referred to the CVW if suspected of having TB. As described, all referred children had either symptoms suggestive of TB, contact with a TB case and/or failure to thrive. Cytokine/chemokine expression in supernatants from stimulated and unstimulated tubes (TB-ag and Nil-, respectively) in the QFT-GIT were analyzed separately. Unstimulated whole-blood supernatants did not identify a P-values o0.05 (*) and o0.01(**) were considered to be significant. The significant P-values are in bold.
a Adjusted for age in months, nutritional status (WHZ and WAZ) and culture positivity for NTM.
Biomarkers for TB infection and disease S Dhanasekaran et al differential cytokine/chemokine expression between the three clinical groups (data not shown). The TB-specific antigenstimulated samples demonstrated significant differences in cytokine/chemokine concentrations for IL-2 (P ¼ 0.009) and IL-13 (P ¼ 0.047) in the latent TB group compared with the uninfected controls ( Figure 3) .
In a previous study, IP-10 has been shown to be a marker of M. tuberculosis infection and disease in children, but could not discriminate between the two. 13 A similar finding was observed in the present study; however, the values failed to reach statistical significance. Previous studies have shown that the expression of IL-2, MCP-1 and IL-13 is increased in adults with TB compared with that in controls. [39] [40] [41] [42] However, the present study shows that compared with that in uninfected controls, the expression of IL-2 and IL-13 is increased in the latent TB group only, whereas the expression of MCP-1 was upregulated in children with latent TB infection; albeit, it did not reach statistical significance. Furthermore, a recent study showed that IFN-g, TNF-a (type 1 cytokines) and IL-13 (type II cytokines) had a reduced expression in children with TB disease compared with that in healthy controls; however, these findings could not be confirmed in the present study. 14 Malnutrition has an impact on the age-dependent maturation of the immune system in children. 43 In the present study, in a rural Indian setting, 440% of the children were malnourished (as measured by wasting, stunting and/or underweight). A high proportion of young children that are malnourished could potentially be a challenge in studies that evaluate TB biomarker(s). Longitudinal studies in similar settings together with the inclusion of additional promising transcriptional biomarkers (for example, IFN-inducible genes as identified in the recent study by Berry et al. 44 ) are crucial to the development of improved diagnostic and treatment modalities for TB.
The strength of this study lies in its prospective design and that it is conducted in a TB-endemic population with low prevalence of HIV infection. The study setting resembles a 'real-life' context and, as a result, the conclusions are clinically relevant. Malnutrition and exposure to NTM are common in children in TB-endemic countries and may limit the generalizability to other populations.
In conclusion, this study in children aged o3 years in a rural Southern India setting, strengthens the evidence for RAB33A as a potential biomarker in children that distinguishes between TB disease and latent TB. Furthermore, CD4 and TGF-b1 at the mRNA level, and IL-2 and IL-13 at the protein level demonstrated some potential to discriminate latent TB from uninfected children. Additional studies in children, together with the inclusion of other candidate biomarkers are required. Such studies are critical for the development of improved TB diagnostic tests for children, particularly in developing countries.
MATERIALS AND METHODS

Study details
The case-control study described here was nested within a prospective longitudinal study of 4382 neonates in Palamaner taluk, Southern India. The neonates included in the study were all BCG-vaccinated by the study team within 72 h of birth and were enrolled within 2 weeks from the date of birth with parental consent. Parents/guardians who did not provide informed consent or who planned to move out from the study area were excluded from the study. The recruited children were randomly (based on the population units where they were born) assigned to active (visited bimonthly; to check for recent TB contact, symptoms and anthropometry; N ¼ 2215) and passive (TB education given to parents/guardian, but with no scheduled home visits; N ¼ 2167) surveillance arms, and monitored at fixed time points, as outlined in the study protocol, for 2 consecutive years. Figure 2 . Results from Lasso analysis of dcRT-MLPA data. The ability of biomarker signatures to predict clinical outcomes (TB disease, latent TB and uninfected controls) was identified following unadjusted and adjusted (age in months, nutritional status (WHZ, WAZ) and culture positivity for NTM) Lasso regression analysis. The predicted probability of the identified biomarker signatures to discriminate between TB disease, latent TB and uninfected controls is shown by: receiver operator characteristics curves (ROCs), area under the curve (AUC) and box-and-whisker plots (5th-95th percentiles). Panels a, b and c display the results from unadjusted Lasso regression analysis and panels d, e and f display the results from adjusted Lasso regression analysis. Table 3 . Bio-plex (10-plex) results based on cytokines/chemokines concentrations from the QFT-GIT supernatant (TB-ag tube) Cytokines/ Chemokines TB disease vs latent TB (P-value) TB disease vs uninfected controls (P-value) Latent TB vs uninfected controls (P-value) P-values o0.05 (*) and o0.01 (**) were considered to be significant. The significant P-values are in bold.
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Parents/guardians were provided with a study identification card with telephonic contacts of the study team physician to ensure follow-up if they visited facilities other than the study diagnostic centre. Out of 4382 children included in the study, 746 children with suggestive symptoms of TB (coughX2 weeks), failure to thrive (unexplained weight loss/delay in a child's growth according to weight for age growth chart, persistent tracking below the 3rd percentile of weight for age) or history of contact with TB patients were sent to the TB CVW at the Emmaus Swiss Hospital, Palamaner, India. At the CVW, the children underwent an anthropometric assessment (age, length and weight) and hemoglobin (Hgb) (heel prick) estimations. Approximately 5 ml blood was drawn for further analyses; 3 ml was collected for the QuantiFERON-TB Gold In-tube (QFT-GIT) assay and the supernatants (plasma) from the Nil, TB antigen (ag) and Mitogen tubes were collected in two microfuge tubes and stored at À 20 1C. One microfuge tube was used for the QFT-GIT assay and the other tube was stored for Bio-Plex assay. Approximately 1.0-2.5 ml blood was collected in PAXgene blood collection tubes (PreAnalytiX (a Qiagen/BD company), Hombrechtikon, Switzerland) and stored at À 80 1C until RNA extraction was performed. Following the collection of the blood sample, a CXR (anteroposterior view) was taken and the TST was administered with 2 TU per 0.1 ml of purified protein derivative RT-23 (Span Diagnostics Ltd., Bangalore, India), and read after 48 h. A cutoff X10 mm was used. In addition, induced sputum and gastric aspirates were collected on each of two consecutive mornings for smear microscopy and culture by MGIT and LJ by standard methods. 45 Positive cultures were confirmed by using the GenoType MTBC kit (Hain Life science GmBH, Nehren, Germany). Direct PCR by COBAS Taqman MTB test (Roche Diagnostics Ltd, Rotkreuz, Switzerland) was undertaken on culture-negative specimen for infants with CXR finding suggestive of TB.
Sample selection for biomarker study Drawing on participants (n ¼ 746) that were referred to the TB CVW, children were classified into four groups according to a generally accepted TB pediatric diagnostic algorithm, 46 which was modified to also include the TST and QFT-GIT results. These were: (a) definite TB-positive for M. tuberculosis by smear/culture, and/or standard PCR (n ¼ 4), (b) probable TB-abnormal changes in CXR (2/3 independent readers reported, an abnormal CXR abnormal) suggestive of pulmonary TB but culture-negative for M. tuberculosis (n ¼ 9). (c) Latent TB-these children were smear-/ culture-negative for M. tuberculosis, had normal CXR and were either TSTpositive, QFT-GIT-positive or positive in both tests (n ¼ 90). (d) Uninfected controls-these children were smear-/culture-negative for M. tuberculosis, TST/QFT-GIT negative, and had normal CXR (n ¼ 107). The combination of definite and probable TB was designated as the TB disease group (n ¼ 13). The uninfected controls were matched on sex to the latent and TB disease groups for use as controls.
RNA extraction
Total RNA was extracted from the PAXgene blood collection tubes using the 'PAXgene Blood RNA kit' with RNase free DNase on-column digestion (PreAnalytiX, Hilden, Germany) according to the manufacturer's instructions. The total RNA concentration and purity (A 260/280 nm ratio) were measured using a Nanodrop spectrophotometer (Thermoscientific, Wilmington, DE, USA) and ranged between 0.4-24.5 mg (average 6.6±4.85 mg). The RNA quality was further assessed by agarose gel electrophoresis.
Dual-color Reverse-Transcriptase Multiplex Ligation-dependent Probe-Amplification (dcRT-MLPA)
As the blood sample available from infants is limited, we used a novel high-throughput technique, which requires only 130-150 ng of total RNA for analyzing a predefined panel of genes of interest. The dcRT-MLPA experiment protocol has been previously described in detail, 16 and is therefore only briefly discussed here. dcRT-MLPA probes and primers (reverse transcription gene target-specific primers, right hand and left hand half MLPA probes, FAM-labeled MLPA primers, HEX-labeled MAPH primers) were obtained from the Department of Infectious Diseases, Leiden Medical University, Leiden, The Netherlands. Samples with a concentration o50 ng ml À 1 were concentrated at 45 1C using a speed vacuum concentrator (Eppendorf AG, Hamburg, Germany). A positive control (using synthetic template oligonucleotides as hybridization templates) and a commercial Human Universal Reference RNA were included on each plate. All samples (n ¼ 210) were run in duplicate. The amplified PCR products were diluted 1:10 with nuclease-free H 2 O and added to a mixture of Hi-Di-Formamide with 400HD ROX size standard. The PCR products were denatured at 95 1C for 5 min and then immediately cooled on ice. Subsequently, the PCR fragments were analyzed on a 3730 capillary sequencer in Gene scan mode (Life Technologies, Carlsbad, CA, USA). Processing of dcRT-MLPA data Data were analyzed using GeneMapper software version 4.0 (Life Technologies) according to the GeneMapper version 4.0 manual. The default peak detection settings were inspected and adjusted if necessary. The peak area (in arbitrary units) of replicates were averaged, then normalized against GAPDH using Microsoft Excel spreadsheet software and log2-transformed as described by Joosten et al. 16 Of the 45 genes, 7 genes had expression levels below the cutoff value of 7.64 (peak areao200 arbitrary units) and one gene CD14, colocalized with a primer-dimer peak and was therefore omitted from further analysis.
Multiplex bead array-Bio-Plex assay For the Bio-Plex assay, we used supernatants from the QFT-GIT assay (Nilag, TB-ag and Mitogen tubes). A pilot study was conducted using 52 randomly selected samples from the biomarker study samples (TB disease (n ¼ 11), latent TB (n ¼ 29) and uninfected controls (n ¼ 12)). The selected 52 samples were tested using the 'Human cytokines 27-plex' kit (Bio-Rad Laboratories Inc., Hercules, CA, USA), according to the manufacturer's instructions. Five of 27 biomarkers (IL-5, IL-13, IP-10, IFN-g and TNF-a) were differentially expressed between the three clinical groups (data not shown) and 5 (IL-2, IL-6, IL-8, IL-10 and MCP-1 (MCAF)) were selected based on previous literature on TB biomarkers, 41, 47, 48 in a customized 10-plex kit. The study samples (n ¼ 210) were then tested on the 10-plex kit. For data analysis, the cytokine/chemokine concentrations (pg ml À 1 ) in the Nil and TB-ag tubes were used. The cytokine/chemokine concentrations in the unstimulated (Nil) and stimulated (TB-ag) tubes were analyzed individually.
Statistical analysis
Differences in baseline characteristics were identified by the Pearson's w 2 test (with Yates continuity correction) or Fisher's exact test. A global test was performed on both transcriptional and translational data, evaluating the null hypothesis that none of the biomarkers were associated with the binary outcome, using the locally most powerful test. 49 Specifically, single biomarkers from both dcRT-MLPA and the Bio-Plex assay were evaluated to determine if the biomarker predicted the TB status considered. These analyses were performed with and without adjusting for age in months, WHZ, WAZ and culture positivity for NTM. No correction for multiple testing was undertaken.
The 'lasso' is a regression model that we used to analyze the transcriptional and translational data sets. This method penalizes the absolute size of the regression coefficients, shrinking them towards zero. This can be an appropriate approach when dealing with highly correlated or interdependent predictors, where standard regression may generate overly generous regression coefficients. 50 It is an alternative to backwards step-wise elimination of non-significant terms, not relying on statistical significance tests. As a result, lasso is useful for establishing a prediction model at an individual level (that is, identifying important predictors), but not for summarizing average trends in the data. 50 The optimal lasso model (that is finding the optimal lambda value or penalty) was determined using leave-one out cross validation. The lasso model corresponding to the lambda value resulting in the smallest prediction error was considered the optimal model. The cross-validation approach replaces the classical adjustment for multiple testing. 50 The prediction performance reported in terms of probabilities and receiveroperator characteristics curves was based on evaluating the optimal lasso model on the test data. The non-zero estimated coefficients were also reported.
A P-value was calculated using two-tailed tests and the P-valueo0.05 was considered as significant. Dot plots were created using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). SPSS software version 19.0 was used for Pearson's w 2 or Fischer's exact testing and binary logistic regression. The statistical environment R was used for the global test 51 to assess the association of the three binary outcomes, that is, TB disease versus latent TB, TB disease versus uninfected controls, and latent TB versus uninfected controls, to establish if all biomarkers had an effect on the binary outcome. For the lasso model the add-on package 'glmnet' was used 52 in R program.
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